Naabak
Naabak is a medicine authorised by Swissmedic under authorisation number 56998. The authorisation holder is THEA Pharma S.A.. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 July 2006 and the authorisation is valid without a time limit. ATC code S01GX03 places the medicine in the group Ophthalmologicals.
| Authorisation number | 56998 |
|---|---|
| Name | Naabak |
| Full name | Naabak, collyre |
| Authorisation holder | THEA Pharma S.A. |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01GX03 |
| First authorisation | 28 July 2006 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Naabak, collyre | B | 28 July 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | ml | S01GX03 | 11.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Naabak authorised in Switzerland?
Yes. Naabak is authorised by Swissmedic under authorisation number 56998, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Naabak have?
Naabak is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Naabak?
The authorisation holder is THEA Pharma S.A.. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.